Chimerix Inc
CMRXDelisted Apr 21, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001117480
Chimerix Inc was delisted on Apr 21, 2025; its insiders filed their last Form 4 on Apr 21, 2025; 119 institutions reported holding it in 13F filings for Q1 2025, worth $618.1M in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 119
- Q1 2025, +49 vs. previous quarter
- 13F value
- $618.1M
- Reported value at the end of Q1 2025
- Superinvestors holding
- 0
- At the end of Q1 2025
Superinvestors holding CMRX, Q1 2025
No superinvestor reported holding CMRX at the end of Q1 2025.
Latest insider trades
Open-market purchases and sales by Chimerix Inc insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 14, 2025 (view filing) | Feb 13 | 1 day | Melemed Allen S.CHIEF MEDICAL OFFICER | SSale | −3.06K | $4.50 | −$13.8K | −2.0%152.9K after | |
| Feb 14, 2025 (view filing) | Feb 13 | 1 day | Andriole Michael T.PRESIDENT AND CEO | SSale | −7.37K | $4.52 | −$33.3K | −1.2%609.6K after | |
| Feb 14, 2025 (view filing) | Feb 13 | 1 day | Alrutz Michael AlbertSVP AND GENERAL COUNSEL | SSale | −1.60K | $4.52 | −$7.23K | −0.7%213.6K after | |
| Feb 14, 2025 (view filing) | Feb 13 | 1 day | Jakeman DavidVP OF FINANCE AND ACCOUNTING | SSale | −300 | $4.53 | −$1.36K | −0.2%149.0K after | |
| Feb 14, 2025 (view filing) | Feb 13 | 1 day | LaSpaluto MichelleCHIEF FINANCIAL OFFICER | SSale | −2.26K | $4.51 | −$10.2K | −1.3%173.0K after | |
| Jan 31, 2025 (view filing) | Jan 30 | 1 day | Jakeman DavidVP OF FINANCE AND ACCOUNTING | SSale | −2.80K | $4.10 | −$11.5K | −1.8%149.3K after | |
| Jan 31, 2025 (view filing) | Jan 30 | 1 day | LaSpaluto MichelleCHIEF FINANCIAL OFFICER | SSale | −1.01K | $4.11 | −$4.17K | −0.6%175.2K after | |
| Jan 31, 2025 (view filing) | Jan 30 | 1 day | Andriole Michael T.PRESIDENT AND CEO | SSale | −2.35K | $4.10 | −$9.63K | −0.4%617.0K after | |
| Aug 9, 2024 (view filing) | Aug 8 | 1 day | Andriole Michael T.PRESIDENT AND CEO | SSale | −1.28K | $0.83 | −$1.07K | −0.3%462.5K after | |
| Feb 16, 2024 (view filing) | Feb 14 | 2 days | Andriole Michael T.PRESIDENT AND CEO | SSale | −1.74K | $1.04 | −$1.81K | −0.4%447.0K after |
Top 10 13F holders, Q1 2025
The largest institutional positions in Chimerix Inc at the end of Q1 2025; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Beryl Capital Management LLC | 3,927,238 | $33.4M | 12.49% | +3,927,238 | New |
| Magnetar Financial LLC | 3,917,413 | $33.3M | 0.44% | +3,917,413 | New |
| Deerfield Management Company, L.P. (Series C) | 3,771,342 | $32.1M | 0.64% | 00.0% | Unchanged |
| Alliancebernstein L.P. | 3,701,006 | $31.5M | 0.01% | +3,701,006 | New |
| Vanguard Group Inc | 3,647,661 | $31.0M | 0.00% | −397,216−9.8% | Reduced |
| Omni Event Management Ltd | 3,502,692 | $29.8M | 3.50% | +3,502,692 | New |
| Glazer Capital, LLC | 3,354,327 | $28.5M | 1.32% | +3,354,327 | New |
| UBS Group AG | 2,901,056 | $24.7M | 0.01% | +2,824,308+3,680.0% | Added |
| Alpine Associates Management Inc. | 2,782,100 | $23.7M | 1.24% | +2,782,100 | New |
| Vivaldi Asset Management, LLC | 2,412,657 | $20.5M | 1.48% | +2,412,657 | New |